{"id":"https://openalex.org/W1972995960","doi":"https://doi.org/10.3987/com-05-10511","title":"A Practical Synthesis of 1-Alkyl-3-amino-4-aryl-1,8-naphthyridin-2-(1H)-one, a Partial Structure of ACAT Inhibitor SMP-797","display_name":"A Practical Synthesis of 1-Alkyl-3-amino-4-aryl-1,8-naphthyridin-2-(1H)-one, a Partial Structure of ACAT Inhibitor SMP-797","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W1972995960","doi":"https://doi.org/10.3987/com-05-10511","mag":"1972995960"},"language":"en","primary_location":{"id":"doi:10.3987/com-05-10511","doi":"https://doi.org/10.3987/com-05-10511","is_oa":false,"landing_page_url":"https://doi.org/10.3987/com-05-10511","pdf_url":null,"source":{"id":"https://openalex.org/S27298842","display_name":"Heterocycles","issn_l":"0385-5414","issn":["0385-5414","1881-0942"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HETEROCYCLES","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103637365","display_name":"Hitoshi Ban","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Hitoshi Ban","raw_affiliation_strings":["Research Division, Sumitomo Pharmaceuticals Co., Ltd., 1-98, Kasugadenaka 3-Chome, Konohana-ku, Osaka 554-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Division, Sumitomo Pharmaceuticals Co., Ltd., 1-98, Kasugadenaka 3-Chome, Konohana-ku, Osaka 554-0022, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054622823","display_name":"Masami Muraoka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masami Muraoka","raw_affiliation_strings":["Research Division, Sumitomo Pharmaceuticals Co., Ltd., 1-98, Kasugadenaka 3-Chome, Konohana-ku, Osaka 554-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Division, Sumitomo Pharmaceuticals Co., Ltd., 1-98, Kasugadenaka 3-Chome, Konohana-ku, Osaka 554-0022, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038534992","display_name":"Kouji Morisita","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kouji Morisita","raw_affiliation_strings":["Research Division, Sumitomo Pharmaceuticals Co., Ltd., 1-98, Kasugadenaka 3-Chome, Konohana-ku, Osaka 554-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Division, Sumitomo Pharmaceuticals Co., Ltd., 1-98, Kasugadenaka 3-Chome, Konohana-ku, Osaka 554-0022, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113589629","display_name":"Naohito Ohashi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naohito Ohashi","raw_affiliation_strings":["Research Division, Sumitomo Pharmaceuticals Co., Ltd., 1-98, Kasugadenaka 3-Chome, Konohana-ku, Osaka 554-0022, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Division, Sumitomo Pharmaceuticals Co., Ltd., 1-98, Kasugadenaka 3-Chome, Konohana-ku, Osaka 554-0022, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5103637365"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1906,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.45668833,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"65","issue":"11","first_page":"2763","last_page":"2763"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13208","display_name":"Synthesis of heterocyclic compounds","score":0.4909999966621399,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13208","display_name":"Synthesis of heterocyclic compounds","score":0.4909999966621399,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13649","display_name":"Advanced Synthetic Organic Chemistry","score":0.17649999260902405,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13859","display_name":"Organic Chemistry Synthesis Methods","score":0.07739999890327454,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acat-inhibitors","display_name":"ACAT inhibitors","score":0.843999981880188},{"id":"https://openalex.org/keywords/acyl-coa-cholesterol-acyltransferase","display_name":"acyl-CoA:cholesterol acyltransferase","score":0.9210000038146973},{"id":"https://openalex.org/keywords/naphthyridinones","display_name":"naphthyridinones","score":0.75},{"id":"https://openalex.org/keywords/intramolecular-aldol-reaction","display_name":"intramolecular aldol reaction","score":0.8510000109672546},{"id":"https://openalex.org/keywords/total-synthesis","display_name":"total synthesis","score":0.45100000500679016},{"id":"https://openalex.org/keywords/cholesterol-esterification","display_name":"cholesterol esterification","score":0.36500000953674316}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9631742238998413},{"id":"https://openalex.org/C2781076698","wikidata":"https://www.wikidata.org/wiki/Q718074","display_name":"Aryl","level":3,"score":0.6167289018630981},{"id":"https://openalex.org/C75079739","wikidata":"https://www.wikidata.org/wiki/Q1571801","display_name":"Intramolecular force","level":2,"score":0.5977550745010376},{"id":"https://openalex.org/C61156836","wikidata":"https://www.wikidata.org/wiki/Q494392","display_name":"Aldol reaction","level":3,"score":0.5277443528175354},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5089280605316162},{"id":"https://openalex.org/C2775970874","wikidata":"https://www.wikidata.org/wiki/Q2609152","display_name":"Acyltransferase","level":3,"score":0.4652811884880066},{"id":"https://openalex.org/C18616679","wikidata":"https://www.wikidata.org/wiki/Q1027170","display_name":"Aldol condensation","level":3,"score":0.4622172713279724},{"id":"https://openalex.org/C2780263894","wikidata":"https://www.wikidata.org/wiki/Q335268","display_name":"Alkyl","level":2,"score":0.46001148223876953},{"id":"https://openalex.org/C37002583","wikidata":"https://www.wikidata.org/wiki/Q418755","display_name":"Sterol O-acyltransferase","level":4,"score":0.45791947841644287},{"id":"https://openalex.org/C155647269","wikidata":"https://www.wikidata.org/wiki/Q243455","display_name":"Medicinal chemistry","level":1,"score":0.3237708806991577},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.2002100646495819},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.16561564803123474},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14817315340042114},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.14102160930633545},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.06442445516586304},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3987/com-05-10511","doi":"https://doi.org/10.3987/com-05-10511","is_oa":false,"landing_page_url":"https://doi.org/10.3987/com-05-10511","pdf_url":null,"source":{"id":"https://openalex.org/S27298842","display_name":"Heterocycles","issn_l":"0385-5414","issn":["0385-5414","1881-0942"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HETEROCYCLES","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1965084980","https://openalex.org/W2178509925","https://openalex.org/W2173667752","https://openalex.org/W2324654959","https://openalex.org/W2038959478","https://openalex.org/W2952097617","https://openalex.org/W1971470471","https://openalex.org/W1600360662","https://openalex.org/W2120067299","https://openalex.org/W2034160087"],"abstract_inverted_index":{"3-Amino-4-[3-(3-benzyloxypropoxy)phenyl]-1-butyl-1,8naphthyridin-2(1H)-one,":[0],"which":[1],"is":[2],"a":[3,7,33],"naphthyridine":[4],"part":[5],"of":[6],"potent":[8],"ACAT":[9],"(acyl-CoA:":[10],"cholesterol":[11],"acyltransferase)":[12],"inhibitor":[13],"SMP-797,":[14],"was":[15],"effectively":[16],"synthesized":[17],"from":[18],"m-bromophenol":[19],"in":[20],"5":[21],"steps":[22],"without":[23],"isolating":[24],"intermediates.The":[25],"synthesis":[26],"involved":[27],"the":[28],"intramolecular":[29],"aldol":[30],"reaction":[31],"as":[32],"key":[34],"step.":[35]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}